Lilly introduces direct-to-employer program for weight-loss drug
Eli Lilly and Co. has launched a platform that offers employers coverage options for obesity care through a partnership with 18 digital health programs.
Eli Lilly and Co. has launched a platform that offers employers coverage options for obesity care through a partnership with 18 digital health programs.
Indiana’s largest life sciences companies and research universities are working to make the state an international leader in chemistry innovation — and they’re ready to launch the first step in a plan called Catalyze Indiana.
Seeking to position Indiana as a global leader in agritechnology and life sciences, Gov. Mike Braun unveiled a lofty goal in a public announcement Tuesday morning.
The Lilly Technology Center investment includes expanding existing capabilities and the establishment of new production lines.
The late-stage results handily beat earlier trials of the company’s diabetes blockbuster Mounjaro, which racked up sales of $23 billion in 2025.
It’s not clear if the new program will represent a big shift in how Indiana currently uses its tax credits. In the past few years, life sciences companies — including Eli Lilly and Co., Elanco Animal Health and others — have received state incentives to expand or retain jobs in Indiana.
The companies developing new weight-loss medicines have a problem: People who don’t lose weight quickly figure out they were assigned to take a placebo and are bailing out of their clinical trials.
Plans call for the basketball court to be open to the public as part of a pocket park concept that will include some new trees and other landscaping.
Kenney was president of the area’s largest construction firm, F.A. Wilhelm Construction Co. Inc., from 2001 until his retirement in 2025.
The series will provide a forum for business and community leaders, local elected officials, academic leaders, entrepreneurs and investors to come together for candid discussions about the opportunities to fuel Indiana’s economic growth.
The Indianapolis-based drugmaker is challenging a $183.7 million judgment in a case brought by a pharmacist who alleged Lilly made false claims about rebates to the federal Medicaid program.
Centessa Pharmaceuticals is developing treatments to address daytime sleepiness and other neurological conditions.
Indiana Landmarks used the downtown property as its Indianapolis and Central Regional Office from 1977 to 2009.
The daily oral medication, which will be branded as Foundayo, is expected to begin shipping Monday.
This weekend’s event will feature nearly 20 interactive fan areas, often called activations, from more than a dozen of the NCAA’s business partners and sponsors.
Pamela Whitten, president of Indiana University, will serve as chair of the IU Inc. board of directors.
Trump wrote that he deemed such actions necessary “to address the threatened impairment of the national security posed by imports of pharmaceuticals and pharmaceutical ingredients.”
Clark participated in a health care-related panel sponsored by Eli Lilly and Co. at the Final Four Fan Fest at the Indiana Convention Center on Friday.
The knowledge and insights gained by studying the humanities enable individuals to develop and hone important skills.
The Indianapolis-based drugmaker has started shipping the new pill to retail pharmacies.